ARMP Armata Pharmaceuticals, Inc.
ARMP Armata Pharmaceuticals, Inc.
Healthcare · Biotechnology
Market read
POC $6.73 · VWAP $7.65 · -41.4% vs 12m avg buyer
collapse vol: normalgaps: overnight-shiftchurn: quiet as of
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
ARMP Price Structure
Loading chart…
Loading timeframes…
Reported EPS $1.20 versus analyst consensus of $-0.44 (+368.5%).
full note →Against street estimates
How ARMP's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Result
Aug 12 -0.441.20+368.5%Beat
May 13 -0.38-3.16-731.6%Miss
Mar 25 -0.19-0.36-89.9%Miss
Nov 12 '25 -0.42-0.33+20.9%Beat
Aug 12 '25 -0.39-0.29+25.3%Beat
May 14 '25 -0.38-0.20+48.1%Beat
Mar 20 '25 -0.35-0.23+33.8%Beat
Nov 13 '24 -0.28-0.15+46.4%Beat
ARMP research tape
1 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.